Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-01-07

Clinical Trial Update: Impact of Nocturnal Hypoxemia on Glucose in High Altitude Sleep Disordered Breathing [NA]

View source ↗

Summary

A clinical trial evaluating nocturnal hypoxemia's effect on glucose in high-altitude sleep-disordered breathing has been withdrawn from the registry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Johns Hopkins University | Conditions: Sleep-Disordered Breathing, Glucose Intolerance | NA | Status: WITHDRAWN